Cover Image

ATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospital

ATRX immunostaining constitutes a routinely used biomarker for the practice of neuropathology. The loss of ATRX expression correlating with ATRX gene alterations is implicated in a wide variety of pediatric and adult gliomas, and has been indexed as a desirable or essential diagnostic criterion for...

Full description

Saved in:
Bibliographic Details
Main Authors: Tauziède-Espariat, Arnault (Author) , Roux, Alexandre (Author) , Benzakoun, Joseph (Author) , Kauv, Paul (Author) , Tazi, Sanaa (Author) , Métais, Alice (Author) , Suwala, Abigail Kora (Author) , Hinz, Felix (Author) , Hasty, Lauren (Author) , Filser, Mathilde (Author) , Masliah-Planchon, Julien (Author) , Saffroy, Raphaël (Author) , Bucau, Margot (Author) , Pallud, Johan (Author) , Varlet, Pascale (Author)
Format: Article (Journal)
Language:English
Published: 13 June 2025
In: Acta Neuropathologica Communications
Year: 2025, Volume: 13, Pages: 1-10
ISSN:2051-5960
DOI:10.1186/s40478-025-02044-6
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s40478-025-02044-6
Get full text
Author Notes:Arnault Tauziède-Espariat, Alexandre Roux, Joseph Benzakoun, Paul Kauv, Sanaa Tazi, Alice Métais, Abigail K. Suwala, Felix Hinz, Lauren Hasty, Mathilde Filser, Julien Masliah-Planchon, Raphaël Saffroy, Margot Bucau, Johan Pallud and Pascale Varlet
Description
Summary:ATRX immunostaining constitutes a routinely used biomarker for the practice of neuropathology. The loss of ATRX expression correlating with ATRX gene alterations is implicated in a wide variety of pediatric and adult gliomas, and has been indexed as a desirable or essential diagnostic criterion for four tumor types featured in the latest world health organization classification of central nervous system Tumors. In adult-type diffuse glioma, the loss of ATRX expression is a hallmark of astrocytoma, IDH-mutant. Recently, novel tumor types and alterations have been referenced in the literature. These include the high-grade astrocytoma with piloid features (HGAP), for which no consistent clinicopathological features have been defined, and the presence of other alterations in the Krebs cycle genes (variants of the Fumarate hydratase -FH- gene) found in gliomas resembling astrocytomas, IDH-mutant. Because of this rapidly evolving classification and histomolecular landscape, we retrospectively analyzed adult gliomas diagnosed over a four consecutive year period to identify supratentorial gliomas, lacking H3 alterations or IDH mutations and harboring a loss of ATRX expression, in order to update their diagnoses in terms of histopathology, genetics and epigenetics. Four specimens (from 620 adult gliomas, 0.7%) were reclassified at the end of the molecular workup, as: 1/ one HGAP, 2/ one malignant transformation with a primitive neuronal component of an astrocytoma, IDH-mutant which lost the IDH2 mutation at recurrence, 3/ a glioma, FH-mutant for which the histopathological and epigenetic features were similar to an astrocytoma, IDH-mutant, and 4/ a glioblastoma, IDH-wildtype. To conclude, these exceptional cases extend the spectrum of ATRX loss in gliomas, beyond the astrocytoma, IDH-mutant and the diffuse hemispheric glioma, H3 G34-mutant.
Item Description:Veröffentlicht: 13. Juni 2025
Gesehen am 28.10.2025
Physical Description:Online Resource
ISSN:2051-5960
DOI:10.1186/s40478-025-02044-6

Similar Items